Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Shockwave Medical Inc SWAV

Healthcare Medical Devices
Shockwave Medical, Inc. is a medical device company. The Company is primarily engaged in the development and commercialization of novel technologies that transform the care of patients with cardiovascular disease. The Company is focused on its intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular and heart valve disease. Built on a balloon catheter platform, the IVL technology uses lithotripsy to disrupt both superficial and deep vascular calcium., while minimizing soft tissue injury, and an integrated angioplasty balloon to dilate blockages at low pressures, restoring blood flow. Its Shockwave M5 IVL catheter and Shockwave M5+ IVL catheter are five-emitter catheters for use in its IVL System in medium-diameter vessels for the treatment of peripheral artery disease (PAD). Its Shockwave S4 IVL catheter is a four-emitter catheter for use in its IVL System in small-diameter vessels for the treatment of PAD.


NDAQ:SWAV - Post by User

Shockwave Medical Inc
<< Previous
 Bullboard Posts
User Avatar Image
(4)
•••
Post by AviseAnalyticson Feb 26, 2024 8:31am
49 Views
Post# 35898637

SHOCKWAVE: TRANSFORMING CARDIOVASCULAR DISEASE TREATMENT

SHOCKWAVE: TRANSFORMING CARDIOVASCULAR DISEASE TREATMENT
$SWAV

Excited to share an article about Shockwave Medical, Inc. (Nasdaq: SWAV), a leading organization that develops and markets innovative technologies for the treatment of cardiovascular diseases. 
 
The Company caters to various segments that have a combined market of over $9.5 billion. Shockwave Medical has consistently grown its revenues from $1.7 million in FY17 to $730.2 million in FY23, which represents a compound annual growth rate (CAGR) of 174%. Over the same period, the number of patients treated with its proprietary technology has increased from about 1,000 to 182,000. The quick acceptance of Shockwave's products in the market and the growing revenues show great potential for the Company, making it an interesting watch.

Read on to know more:

https://www.aviseanalytics.com/shockwave-transforming-cardiovascular-disease-treatment/
 
<< Previous
 Bullboard Posts
Dealroom for high-potential pre-IPO opportunities